Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paris | Consumer Cyclicals | Leisure Products | €2.07B | 5.6x | 0.14 | €106.70 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 68.2% Upside | Upgrade to Pro+ | ||
Paris | Consumer Cyclicals | Media & Publishing | €107M | 4.7x | -0.06 | €2.01 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 263.6% Upside | Upgrade to Pro+ | ||
Paris | Consumer Cyclicals | Leisure Products | €41.76M | 11.1x | -0.19 | €10.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 62% Upside | Upgrade to Pro+ | ||
Paris | Technology | Telecommunications Services | €28.50M | 9.1x | 8.69 | €4.30 | -14% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 714% Upside | Upgrade to Pro+ | ||
Paris | Financial | Investment Holding Companies | €12.87M | -24.5x | 0.14 | €0.99 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 253.5% Upside | Upgrade to Pro+ | ||
Paris | Healthcare | Biotechnology & Medical Research | €664.13K | -0.8x | -0.01 | €0.19 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6,150% Upside | Upgrade to Pro+ |